Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Liquidia Corporation - Common Stock (NQ:LQDA)

12.93 -1.20 (-8.49%)
Streaming Delayed Price Updated: 2:55 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
Where Liquidia Stands With Analysts
Via Benzinga
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
From Liquidia Corporation
Via GlobeNewswire
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia: Q1 Earnings Insights
Via Benzinga
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Earnings Outlook For Liquidia
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Needham Maintains Buy Rating for Liquidia: Here's What You Need To Know
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash. 
Via Benzinga
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
From Liquidia Corporation
Via GlobeNewswire
Liquidia Technologies's Earnings: A Preview
Via Benzinga
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
These seven high-risk stocks could ultimately rocket to the moon, or fall to the depths of the stock market graveyard. 
Via InvestorPlace
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications
From Liquidia Corporation
Via GlobeNewswire
NVIDIA To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Friday
Wells Fargo raised the price target for Warner Bros. Discovery, Inc. (NASDAQ: WBD) from $13 to $20. Wells Fargo analyst Steven Cahall upgraded the stock from Equal-Weight to Overweight. Warner Bros.... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
From Liquidia Corporation
Via GlobeNewswire
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.